在癌症患者中,肺栓塞相关的死亡率
Marco Zuin1,2, Anju Nohria3, Stanislav Henkin4
1Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
JAMA network open
|February 18, 2025
概括
尽管癌症死亡率下降,但美国癌症患者的年龄调整肺栓塞 (PE) 死亡率在2011-2020年期间上升. 这一趋势在年轻人和特定的人口群体中尤其令人担忧.
科学领域:
- 在瘤学瘤学.
- 心血管医学 心血管医学
- 公共卫生 公共卫生
背景情况:
- 急性肺栓塞 (PE) 是癌症患者死亡的重要原因.
- 了解PE相关死亡率的趋势对于改善患者的治疗结果至关重要.
研究的目的:
- 分析2011年至2020年美国癌症患者中PE相关死亡率的趋势.
- 检查各种人口和地理子组的这些趋势.
主要方法:
- 一项使用CDC流行病学研究 (WONDER) 数据库的广泛在线数据的队列研究.
- 对15岁以上癌症患者的PE年龄调整死亡率 (AAMR) 的分析.
- 加入点回归建模来评估趋势和平均年均百分比变化 (AAPC).
主要成果:
- 癌症患者的PE相关死亡率AAMR每年增加2.5% (2011-2020年).
- 在年轻的成年人 (15-64岁),特定的种族/种族群体和美国南部地区观察到增加.
- 癌症发病率和死亡率下降,但癌症诊断和死亡的绝对数量上升.
结论:
- 根据年龄调整的PE相关死亡率在美国癌症患者中增加,尽管癌症死亡率下降.
- 在年轻人和特定人群中PE死亡率的上升需要进一步调查.
- 结果可以指导研究PE预防和治疗在癌症护理.
相关概念视频
Cancer Survival Analysis
321
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
321
Other Pulmonary Disorders
797
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
797
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Radiological Investigation III: Pulmonary Angiogram and PET Scan
82
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
82
Pneumothorax-II
117
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
117
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K


